IRIS
TOMASSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.520
EU - Europa 783
AS - Asia 663
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.515
SG - Singapore 533
IE - Irlanda 271
IT - Italia 194
RU - Federazione Russa 78
SE - Svezia 70
CN - Cina 63
GB - Regno Unito 47
DE - Germania 36
VN - Vietnam 33
FI - Finlandia 19
UA - Ucraina 11
AU - Australia 9
BE - Belgio 9
TR - Turchia 9
FR - Francia 8
HK - Hong Kong 8
CZ - Repubblica Ceca 7
RO - Romania 7
ES - Italia 6
IN - India 6
IR - Iran 5
BG - Bulgaria 4
CA - Canada 4
CH - Svizzera 3
AT - Austria 2
EU - Europa 2
MD - Moldavia 2
PK - Pakistan 2
PT - Portogallo 2
TW - Taiwan 2
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
JP - Giappone 1
MC - Monaco 1
ME - Montenegro 1
MN - Mongolia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.980
Salva come PNG Salva come JPEG
Città #
Singapore 483
Chandler 286
Dublin 268
Santa Clara 147
Ashburn 108
Jacksonville 83
Princeton 82
Altamura 41
Los Angeles 34
Beijing 33
Dong Ket 33
Wilmington 29
Washington 20
Munich 19
Chieti 17
Rome 16
Ann Arbor 15
Seattle 15
Romola 14
Teramo 13
Falls Church 12
New York 12
Boardman 11
Helsinki 10
Milan 10
Moscow 10
Pescara 10
Brussels 9
Fairfield 8
Hong Kong 8
London 8
Southend 8
Chicago 7
Lappeenranta 7
Saint Petersburg 7
Woodbridge 7
Norwalk 6
Santander 6
Sydney 6
Camerino 5
Cardiff 5
Frankfurt am Main 5
Nanchang 5
Oxford 5
Pune 5
Tehran 5
Brno 4
Edinburgh 4
Houston 4
Istanbul 4
Izmir 4
Hanover 3
Kensington 3
Menlo Park 3
Nuremberg 3
San Vito Chietino 3
Bosio 2
Cambridge 2
Cedar Lake 2
Città Sant'Angelo 2
Dallas 2
Dearborn 2
Elk Grove Village 2
Florence 2
Genoa 2
Iasi 2
Melbourne 2
Olomouc 2
Ottawa 2
Pianella 2
Pisa 2
Pontecorvo 2
Secaucus 2
Sofia 2
Southwark 2
Toritto 2
Turin 2
Vetroz 2
Zhongli District 2
Alba Adriatica 1
Amsterdam 1
Auckland 1
Bratislava 1
Buffalo 1
Burgas 1
Campobasso 1
Campodipietra 1
Chisinau 1
Clearwater 1
Copenhagen 1
Cormeilles-en-Parisis 1
Dongguan 1
Forest City 1
Guangzhou 1
Hamminkeln 1
Hangzhou 1
Hengshui 1
Irsina 1
Isernia 1
Jiaxing 1
Totale 2.055
Salva come PNG Salva come JPEG
Nome #
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 82
Modelling the natural history of primary progressive multiple sclerosis 81
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 80
Neuroplasticity and motor rehabilitation in multiple sclerosis 76
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 74
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 73
Oral contraceptives combined with interferon b in multiple sclerosis 69
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 69
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 68
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 68
Brain morphometry in Multiple Sclerosis 67
Tractography in the presence of multiple sclerosis lesions 66
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 66
Neurological update: MOG antibody disease 60
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 60
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 59
Predicting the profile of increasing disability in multiple sclerosis 58
Informing MS patients on treatment options: a consensus on the process of consent taking 58
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 58
How common is truly benign MS in a UK population? 57
Site-specific clinical disease onset in multiple sclerosis 56
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 54
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 53
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 53
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 52
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 51
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 51
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 49
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 44
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 43
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 41
Medical education and MS: getting the training right 40
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 40
Diagnosis and management of multiple sclerosis: MRI in clinical practice 39
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 38
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 37
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 36
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 35
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 34
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 34
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 34
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 32
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 32
Similarities and differences between multiple sclerosis and type 1 diabetes 31
Neuroplasticity and functional recovery in multiple sclerosis 30
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 30
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 27
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 27
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 26
Preservation of motor skill learning in patients with multiple sclerosis 25
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 25
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 24
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 24
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 24
Model-free characterization of brain functional networks for motor sequence learning using fMRI 24
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 24
Contemporary study of multiple sclerosis disability in South East Wales 24
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 22
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 22
Age-related changes in grey and white matter structure throughout adulthood 22
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 22
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 22
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 21
Structural and functional bases for individual differences in motor learning 21
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 21
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 20
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 20
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 20
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 19
Multiple sclerosis lesions: insights from imaging techniques 19
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 19
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 19
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 19
Relating brain damage to brain plasticity in patients with multiple sclerosis 18
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 18
Changes in brain perfusion with training-related visuomotor improvement in MS 18
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 18
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 16
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 16
Lessons from immunotherapies in multiple sclerosis 16
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 16
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 15
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 15
Sex hormones: a role in the control of multiple sclerosis? 14
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 14
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 14
Sex hormones, brain damage and clinical course of Multiple Sclerosis 13
Alexithymia in multiple sclerosis: relationship with fatigue and depression 13
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 13
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 12
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 12
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 11
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 11
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 11
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride 10
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 9
Transverse myelitis in children and adults 6
Totale 3.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 1 1 3 3 31 104 57 13
2020/2021185 21 18 35 7 2 29 8 14 6 5 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20251.173 120 544 421 52 36 0 0 0 0 0 0 0
Totale 3.349